Condition
Prostate Cancer (CRPC) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Prostate Cancer (CRPC) clinical trials that are recruiting, at sites in 2 countries (most in China (2), United States (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 2Countries
Newest Prostate Cancer (CRPC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tinengotinib with a novel endocrine therapy for metastatic castration-resistant prostate cancer | Phase 2 | Fuzhou, Fujian and 15 other locations | Recruiting | Oct 13, 2026 |
| Post-prostatectomy SBRT with MRI/CT adaptive guidance to reduce urinary and bowel side effects | — | Los Angeles, California | Recruiting | Jul 22, 2025 |
| Treatment for advanced prostate cancer using Pluvicto | Phase 2 | Houston, Texas | Recruiting | May 15, 2025 |
| Investigating the bioequivalence of triprerelin acetate injections for prostate cancer | Phase 1 | Qingdao, Shandong | Recruiting | Nov 12, 2024 |
All recruiting trials (4)
-
Tinengotinib with a novel endocrine therapy for metastatic castration-resistant prostate cancer
This study tests whether tinengotinib plus an ARPI (darolutamide or enzalutamide) is safe and helps people whose metastatic castration-resistant prostate cancer has progressed on prior ARPI therapy.
-
Post-prostatectomy SBRT with MRI/CT adaptive guidance to reduce urinary and bowel side effects
This registry will try MRI- or CT-guided stereotactic body radiotherapy (SBRT), sometimes using on-table adaptive planning, for men after prostatectomy who have adverse pathology or a rising PSA.
-
Treatment for advanced prostate cancer using Pluvicto
This study is testing if a new treatment called Pluvicto can help men with advanced prostate cancer that has spread to their bones feel better and improve their quality of life.
-
Investigating the bioequivalence of triprerelin acetate injections for prostate cancer
This study is testing if two different versions of a prostate cancer injection work the same way for men with the disease who haven't had similar treatments before.
Related topics
Quick answers
How many Prostate Cancer (CRPC) clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.